Gentiva Reports Fourth Quarter and Fiscal 20...(2717 290786 Other Related Ser...)

Date:2/18/2009

2,717 290,786 Other Related Services 33,989 30,575 128,229 121,797 Intersegment revenues (365) (948) (3,034) (5,115) ---- ---- ------ ------ Total net revenues $282,930 $313,396 $1,300,438 $1,229,297 ======== ======== ========== ========== Operating contribution (3) Home Health $41,769 $30,069 $151,235 $122,053 CareCentrix (4) - 7,180 18,074 29,070 Other Related Services 3,489 3,593 12,535 13,821 ----- ----- ------ ------ Total operating contribution 45,258 40,842 181,844 164,944 Corporate expenses (15,249) (15,539) (67,716) (65,268) Gain on sale of business, net 61 - 107,933 - Depreciation and amortization (5,550) (5,308) (22,044) (20,013) Interest expense, net (2,489) (5,868) (17,087) (24,081) ------ ------ ------- ------- Income before income taxes $22,031 $14,127 $182,930 $55,582 ======= ======= ======== ======= 4th Quarter Fiscal Year ----------- ----------- 2008 2007 2008 2007 ---- ---- ---- ---- Net Revenues by Major Payer Source: Medicare Home Health $176,508 $140,111 $648,022 $549,262 Other 20,117 15,527 68,052 60,285
'/>"/>

SOURCE Gentiva Health Services, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Gentiva Reports Strong Second Quarter led by Home Health Segment
2. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results